Literature DB >> 12791889

Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis.

Thomas J Novicki1, Karen LaFe, Lynda Bui, Uyen Bui, Robert Geise, Kieren Marr, Brad T Cookson.   

Abstract

Primarily saprophytic in nature, fungi of the genus Acremonium are a well-documented cause of mycetoma and other focal diseases. More recently, a number of Acremonium spp. have been implicated in invasive infections in the setting of severe immunosuppression. During the course of routine microbiological studies involving a case of fatal mycosis in a nonmyeloablative hematopoietic stem cell transplant patient, we identified a greater-than-expected variation among strains previously identified as Acremonium strictum by clinical microbiologists. Using DNA sequence analysis of the ribosomal DNA intergenic transcribed spacer (ITS) regions and the D1-D2 variable domain of the 28S ribosomal DNA gene (28S), the case isolate and four other clinical isolates phenotypically identified as A. strictum were found to have <99% homology to the A. strictum type strain, CBS 346.70, at the ITS and 28S loci, while a sixth isolate phenotypically identified only as Acremonium sp. had >99% homology to the type strain at both loci. These results suggest that five out of the six clinical isolates belong to species other than A. strictum or that the A. strictum taxon is genetically diverse. Based upon these sequence data, the clinical isolates were placed into three genogroups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791889      PMCID: PMC156529          DOI: 10.1128/JCM.41.6.2623-2628.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

2.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Infection due to the fungus Acremonium (cephalosporium).

Authors:  R M Fincher; J F Fisher; R D Lovell; C L Newman; A Espinel-Ingroff; H J Shadomy
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

4.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

Review 5.  Aspergillosis. The spectrum of the disease in 98 patients.

Authors:  R C Young; J E Bennett; C L Vogel; P P Carbone; V T DeVita
Journal:  Medicine (Baltimore)       Date:  1970-03       Impact factor: 1.889

6.  Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis.

Authors:  J W Fell; T Boekhout; A Fonseca; G Scorzetti; A Statzell-Tallman
Journal:  Int J Syst Evol Microbiol       Date:  2000-05       Impact factor: 2.747

7.  Fungal infections in bone marrow transplant patients.

Authors:  J D Meyers
Journal:  Semin Oncol       Date:  1990-06       Impact factor: 4.929

8.  Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species.

Authors:  T J Lott; R J Kuykendall; E Reiss
Journal:  Yeast       Date:  1993-11       Impact factor: 3.239

9.  Ribosomal DNA internal transcribed spacers are highly divergent in the phytopathogenic ascomycete Fusarium sambucinum (Gibberella pulicaris).

Authors:  K O'Donnell
Journal:  Curr Genet       Date:  1992-09       Impact factor: 3.886

10.  Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.

Authors:  M R O'Donnell; G M Schmidt; B R Tegtmeier; C Faucett; J L Fahey; J Ito; A Nademanee; J Niland; P Parker; E P Smith
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

View more
  10 in total

1.  Multilocus DNA sequence comparisons rapidly identify pathogenic molds.

Authors:  Jennifer L Rakeman; Uyen Bui; Karen Lafe; Yi-Ching Chen; Rhonda J Honeycutt; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.

Authors:  Fabiola Fernández-Silva; Javier Capilla; Emilio Mayayo; Deanna Sutton; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

3.  Acremonium strictum: Report of a Rare Emerging Agent of Cutaneous Hyalohyphomycosis with Review of Literatures.

Authors:  Ajanta Sharma; N K Hazarika; Purnima Barua; M R Shivaprakash; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2013-10-12       Impact factor: 2.574

4.  Identification of medically important molds by an oligonucleotide array.

Authors:  Chen Ren Hsiao; Liyin Huang; Jean-Philippe Bouchara; Richard Barton; Hsin Chieh Li; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 5.  Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.

Authors:  Shukla Das; Rumpa Saha; Sajad Ahmad Dar; V G Ramachandran
Journal:  Mycopathologia       Date:  2010-06-25       Impact factor: 2.574

6.  Acremonium kiliense: reappraisal of its clinical significance.

Authors:  Ziauddin Khan; Khaled Al-Obaid; Suhail Ahmad; Amal Abdel Ghani; Leena Joseph; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

7.  Spectrum of clinically relevant Acremonium species in the United States.

Authors:  H Perdomo; D A Sutton; D García; A W Fothergill; J Cano; J Gené; R C Summerbell; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

8.  Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium.

Authors:  R C Summerbell; C Gueidan; H-J Schroers; G S de Hoog; M Starink; Y Arocha Rosete; J Guarro; J A Scott
Journal:  Stud Mycol       Date:  2011       Impact factor: 16.097

9.  Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.

Authors:  Fabiola Fernández-Silva; Javier Capilla; Emilio Mayayo; Deanna A Sutton; Pilar Hernández; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

10.  The Protean Acremonium. A. sclerotigenum/egyptiacum: Revision, Food Contaminant, and Human Disease.

Authors:  Richard C Summerbell; Cecile Gueidan; Josep Guarro; Akif Eskalen; Pedro W Crous; Aditya K Gupta; Josepa Gené; Jose F Cano-Lira; Arien van Iperen; Mieke Starink; James A Scott
Journal:  Microorganisms       Date:  2018-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.